Emerging research suggest Retatru tide , a dual stimulator targeting both GLP-1 and GIP , may offer a promising development for weight treatment. Early patient trials have demonstrated substantial losses in body fat , possibly surpassing other obesity medications . However , further study is necessary to completely determine its lasting impact and